advertisement
OBJECTIVES: To evaluate satisfaction and compliance in glaucoma and ocular hypertensive patients receiving a fixed combination treatment. MATERIALS AND METHODS: After instilling a fixed combination, patients were asked to fill out a questionnaire about their satisfaction and compliance at baseline and 15 days after the onset of new therapy. RESULTS: In the study, 1693 glaucoma patients (G) and 621 ocular hypertensive (OHT) patients were included. Mean age was 65.6 ± 11.7 years. Onset of disease was 7.2 ± 6.6 years and 5.2 ± 4.9 years for G and OHT patients, respectively. Insufficient efficacy of the previous topical treatment (monotherapy in 55% of cases) was the main cause for shifting to a fixed combination in 70% of cases. Satisfaction was increased in 15% of the patients and compliance was increased in 25% of the patients. DISCUSSION: Fixed combination provides an easier regimen and therefore encourages better compliance, a key issue in a chronic disease such as glaucoma. LA: French
Dr. A. Bron, Service d'Ophtalmologie, CHU Hôpital Général, Dijon, France